Company*
(Country;
Symbol)

Company
(Country;
Symbol)

Type/Product Area

Terms/Details (Date)


Angiotech
Pharmaceuticals
Inc.
(ANPI)

Edwards Lifesciences Corp. (NYSE:EW)

Agreement regarding the distribution of Angiotech's Vascular Wrap paclitaxel-eluting mesh/ePTFE graft combination product

Angiotech now has the exclusive rights to distribute the product through its own sales force and distribution network in Europe (5/10)

Cronos
Therapeutics
Ltd.
(subsidiary
of ValiRx plc;
UK; LSE:VAL)

Cancer Research Technology Ltd.* (UK)

Extended agreement that allows for the addition of three new potential GeneICE compounds to the collaboration

The agreement originally focused on one compound and its potential in halting the development and growth of cancerous cells by preventing the transcription of specific genes involved in tumorigenesis (5/14)

Evotec AG
(Germany;
FSE:EVT)

Panacos Pharmaceuticals Inc.(PANC)

Extended ongoing discovery collaboration with Evotec into its fourth year

Evotec has supported Panacos since 2004 in identifying novel compounds for treating viral infection (5/10)


Notes:
* Private companies are indicated with an asterisk.
Unless otherwise noted, stock symbols listed are on the Nasdaq market.
FSE = Frankfurt Stock Exchange; LSE = London Stock Exchange; NYSE = New York Stock Exchange.

No Comments